This inventor holds 1 USPTO granted patent and 5 published patent applications and 1 EPO patent. Top assignee: Kiniksa Pharmaceuticals, Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of James Kranz
Introduction
James Kranz is an accomplished inventor based in Lexington, MA (US). He is known for his significant contributions to the field of pharmaceuticals, particularly in the development of innovative antibody formulations. With a focus on humanized anti-CD40 antibodies, Kranz has made strides in advancing medical treatments.
Latest Patents
James Kranz holds a patent for a pharmaceutical composition of a humanized anti-CD40 antibody. This patent features a pharmaceutical formulation containing the anti-CD40 antibody known as KPL-404. This innovation has the potential to impact therapeutic approaches in various medical conditions.
Career Highlights
Throughout his career, Kranz has worked with notable companies in the pharmaceutical industry. He has been associated with Kiniksa Pharmaceuticals, Ltd. and Oak Hill Bio Limited. His experience in these organizations has contributed to his expertise in developing cutting-edge pharmaceutical solutions.
Collaborations
James Kranz has collaborated with talented professionals in his field, including Nazila Salamat-Miller and Katherine Taylor. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
James Kranz's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the realm of anti-CD40 antibodies, highlight the importance of research and development in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile